Zions Bancorporation, National Association’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.4K Sell
185
-12
-6% -$6.73K 0.01% 433
2026
Q1
$111K Sell
197
-204
-51% -$131K 0.01% 399
2025
Q4
$271K Buy
401
+56
+16% +$38.1K 0.01% 388
2025
Q3
$220K Buy
345
+192
+125% +$117K 0.01% 363
2025
Q2
$82.1K Buy
153
+23
+18% +$11K ﹤0.01% 444
2025
Q1
$54.6K Buy
+130
New +$56.4K ﹤0.01% 473

Other funds holding IDXX

Zions Bancorporation, National Association's IDXX Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Idexx Laboratories (IDXX) stake by 6.1% in Q2 2026, selling an estimated $6.73K and leaving 185 shares worth $97.4K. The position accounts for 0.01% of the portfolio, ranked #433.

Zions Bancorporation, National Association first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $271K in Q4 2025. 545 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Zions Bancorporation, National Association held 185 shares of Idexx Laboratories worth $97.4K as of Q2 2026.
  • Zions Bancorporation, National Association sold 12 Idexx Laboratories shares in Q2 2026, an estimated $6.73K.
  • Idexx Laboratories made up 0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #433 holding.
  • Zions Bancorporation, National Association first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Idexx Laboratories position peaked at $271K in Q4 2025.
  • 545 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.